📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

From genomics to targeted treatment in haematological malignancies: a focus on acute myeloid leukaemia. (2018)

First Author: Jakobsen NA

Attributed to: Clinical Investigation of a Humanized Anti-CD47 Antibody in Targeting Cancer Stem Cells in Acute Myelodi Leukaemia (and Solid Tumours). funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7861/clinmedicine.18-2-s47

PubMed Identifier: 29700093

Publication URI: http://europepmc.org/abstract/MED/29700093

Type: Journal Article/Review

Volume: 18

Parent Publication: Clinical medicine (London, England)

Issue: Suppl 2

ISSN: 1470-2118